Xiang-Min Zhang Selected Research

Disease Progression

1/2019

Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiang-Min Zhang Research Topics

Disease

2	Neoplasms (Cancer) 01/2023 - 06/2022
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2022 - 01/2019
1	Brain Diseases (Brain Disorder) 01/2024
1	Central Nervous System Diseases (CNS Diseases) 01/2024
1	Carcinoma (Carcinomatosis) 01/2023
1	Carcinogenesis 01/2023
1	Ischemia 06/2022
1	Disease Progression 01/2019
1	Congenital Abnormalities (Deformity) 08/2017
1	Knee Osteoarthritis 08/2017
1	Snoring 05/2015
1	Sleepiness 05/2015
1	Neuralgia (Stump Neuralgia) 07/2009
1	Coma (Comas) 02/2009
1	Wounds and Injuries (Trauma) 02/2009
1	Optic Nerve Injuries 02/2009
1	Severe Acute Respiratory Syndrome 11/2007
1	Infections 11/2007
1	Hemorrhage 09/2006
1	Osteoradionecrosis 09/2006
1	Nasopharyngeal Carcinoma 09/2006

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
1	ethanolamine kinaseIBA 01/2023
1	Hemostatics (Antihemorrhagics)IBA 06/2022
1	SteroidsIBA 02/2009
1	Protein SIBA 11/2007
1	Neutralizing AntibodiesIBA 11/2007
1	VaccinesIBA 11/2007

Therapy/Procedure

1	Therapeutics 01/2024
1	Nephrectomy 06/2022
1	Lasers (Laser) 06/2022
1	Osteotomy 08/2017
1	Laryngoscopes 05/2015
1	Endoscopes 07/2009
1	Decompression 02/2009
1	Radiotherapy 09/2006
1	Conservative Treatment 09/2006